Editorial Article
Charting the future of oligonucleotide bioanalysis
As oligonucleotide therapeutics reshape drug discovery, AAPS is leading a collaborative effort to establish robust bioanalytical strategies
Through extensive research, experimentation, and clinical trials, experts in the field of drug discovery and development identify promising biopharmaceutical or pharmaceutical drug candidates, optimize their efficacy and safety profiles, and navigate regulatory processes for eventual market approval. From innovative therapies to groundbreaking treatments, this dynamic scientific field plays a pivotal role in revolutionizing medicine and saving lives.
As oligonucleotide therapeutics reshape drug discovery, AAPS is leading a collaborative effort to establish robust bioanalytical strategies